rs75569266
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001080449.3(DNA2):c.2782G>A(p.Val928Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00533 in 1,612,212 control chromosomes in the GnomAD database, including 390 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001080449.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DNA2 | NM_001080449.3 | c.2782G>A | p.Val928Ile | missense_variant | 18/21 | ENST00000358410.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DNA2 | ENST00000358410.8 | c.2782G>A | p.Val928Ile | missense_variant | 18/21 | 1 | NM_001080449.3 | P1 | |
DNA2 | ENST00000440722.2 | c.748G>A | p.Val250Ile | missense_variant | 5/7 | 1 | |||
DNA2 | ENST00000551118.6 | c.2068G>A | p.Val690Ile | missense_variant | 14/17 | 5 | |||
DNA2 | ENST00000399179.6 | c.*603G>A | 3_prime_UTR_variant, NMD_transcript_variant | 19/22 | 2 |
Frequencies
GnomAD3 genomes ? AF: 0.0291 AC: 4427AN: 152088Hom.: 196 Cov.: 32
GnomAD3 exomes AF: 0.00728 AC: 1811AN: 248926Hom.: 81 AF XY: 0.00523 AC XY: 706AN XY: 135038
GnomAD4 exome AF: 0.00285 AC: 4155AN: 1460006Hom.: 194 Cov.: 30 AF XY: 0.00242 AC XY: 1756AN XY: 726406
GnomAD4 genome ? AF: 0.0291 AC: 4434AN: 152206Hom.: 196 Cov.: 32 AF XY: 0.0274 AC XY: 2041AN XY: 74428
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 24, 2015 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
not provided Benign:2
Benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Oct 25, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 29, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at